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Effects of Prenatal Drug Exposure
on Neurobehavioral Functioning
in Young Infants
Yvette Blanchard
Patricia E. Suess
Marjorie Beeghly
ABSTRACT. In the newborn period, infants prenatally exposed to
cocaine and other drugs show low scores on the Neonatal Behavioral
Assessment Scale. Beyond that period, research is limited on the effects
of prenatal drug exposure on neurobehavioral functioning. In this study
we compared infants exposed to cocaine and other drugs and control
infants from low socioeconomic backgrounds on measures of neurobehavioral functioning during neuromotor assessment at 1, 4 and 7
months of life. None of the measures of neurobehavioral functioning
showed any significant group differences. This study did not support
the hypothesis of disrupted neurobehavioral functioning beyond the
neonatal period in infants exposed to drugs prenatally. [Article copies
available for a fee froin The Haworth Document Delivery Service:
1-800-342-9678.E-mail address: getiiifo@ha worthpressitic. coin]
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Since the 1980s, the availability of crack cocaine at low cost has contributed to an increase in the number of pregnant women who use it as well as
other illegal drugs during pregnancy.' Reported incidences of prenatal cocaine use vary from 8% to 18%,2-5with a study conducted in Detroit revealing an incidence as high as 31% on meconium testing.6 Due to its low
molecular weight and its water and lipid solubility, cocaine readily crosses
the placenta and the fetal blood-brain barrier.7 Cocaine affects the monoaminergic neurotransmitter system (dopamine, norepinephrine and serotonin)
in the central nervous system (CNS) through its action on the neurotransmitter release, reuptake, and recognition at the synaptic j ~ n c t i o n . In
~ -humans,
~
these neurotransmitters are present in neural pathways that prqject to brain
areas involved in neurologic and behavioral functions including arousal,
regulation of attention, response to sensory stimuli, and the modulation of
mood states. lo,
Neurotransmitters play an important role in fetal brain development
through their influence on neuronal migration and differentiation, synaptic
proliferation and on the development of receptor
Although full
scientific support for the suspected cocaine-induced changes in the human
fetal neurotransmitter system and their ensuing neurodevelopmental consequences is still lacking, preliminary research has shown results suggestive of
such a relationship. In a recent study with newborn infants, Mirochnick and
colleagues14 showed that plasma norepinephrine concentrations were higher
in infants who had been prenatally exposed to cocaine and mari.juana than in
unexposed infants. Among the exposed infants, plasma norepinephrine concentrations were associated with a decreased responsivity to social and nonsocial auditory and visual stimuli and higher levels of depressed behavior on
the Neonatal Behavioral Assessment Scale (NBAS). Of note, these associations remained significant even when controlling for the effects of prenatal
marijuana exposure. In a rare study with human infants, Needlman and his
colleagues15 examined the relation between prenatal cocaine exposure and
the presence of monoamine precursors and metabolites in the central nervous
system. Relative to unexposed infants, infants who had been prenatally exposed to cocaine had decreascd levels of homovanill ic acid, the principal
metabolite of dopamine, in their cerebrospinal fluid. These findings suggest
that prenatal cocaine exposure may result in changes in central dopaminergic
systems in the human neonate.15
Many investigators have reported that prenatal cocaine and polydrug exposure is significantly related to compromised infant neurobehavioral pcrformance on the NBAS, although specific findings vary across
Compared to unexposed neonates, neonates with a history of prenatal cocaine
and polydrug exposure exhibit poorer state r e g ~ l a t i o n ,motor
~ ~ ~ maturi~~~'~
ty,16 orientation,lh habituation20,21and greater e~citabi1ity.l~
In some stud-

Phys Occup Ther Pediatr Downloaded from informahealthcare.com by Sacred Heart University on 09/30/13
For personal use only.

Research Reports

21

i e ~ , ’ ~these
? ’ ~ findings remained significant even when the effects of confounding variables such as birthweight and prenatal exposure to other drugs
were controlled analytically. Moreover, significant dose-related effects of
prenatal cocaine exposure have been reported for infant NBAS performance.’8>’9
Clinically, full-term infants who have been exposed prenatally to cocaine
and other drugs have been described as being easily overstimulated and
requiring increased examiner intervention in order to maintain control of
their hyperexcitable nervous systems.lh This hypersensitivity and need for
examiner intervention is still described at one month of age.I6 Some exposed
infants are unable to tolerate even low levels of stimulation and quickly reach
an agitated crying state.
Early detection of neurobehavioral abnormalities such as those revealed
on the NBAS is important for infants prenatally exposed to drugs and other
high risk infants. These behaviors may represent early manifestations of
potential insult to the nervous system which may contribute to later compromised developmental outcome. Unfortunately, few developmental assessments designed to capture neurobehavioral organization beyond the newborn
period are available.a-’
Most investigators have used the Bay ley Scales of Infant Development
(BSID) or other psychometric assessments to evaluate the effects of prenatal
cocaine exposure on infant outcome beyond the neonatal period. In the majority of these studies, prenatal cocaine exposure was not significantly related
to infants’ performance on either the Mental Developmental Index (MDI) or
the Psychomotor Developmental Index (PDI).2“26 Billman and colleagues27
reported that PDI scores varied according to infant exposure status, but o n l y
when infant cthnicity was considered. That is, black infants who had been
exposed to cocaine and other drugs had higher PDI than black control infants;
however, no significant difference was reported for white infants.” In other
research Singer and associates2s reported differences on the BSID MDI at 12
months favoring the control group.
Psychometric assessments such as the BSID may be too limited in sensitivity and specificity to detect subtle neurobehavioral deficits that may be
associated with prenatal drug e x p o s ~ r e . ” >Beeghly
~ ~ > ~ ~and Brazelton2?’have
demonstrated that qualitative dimensions of two-year-old behavior assessed
during the BSID can significantly discriminate biological at-risk small for
gestational age (SGA) infants from non-SGA infants, even when the BSID
scorcs did not. The instrument used in this study, the Qualifier Scoring
System for Toddlers (QSS-T), was adapted from the NBAS supplementary
items and measured the quality of a child’s responsiveness during testing on
the BSID. In their study, SGA toddlers exhibited more attentional dysregula-
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tion and more negative affect during the BSID than non-SGA toddlers, and
required more examiner persistence to complete testing.
Standard measurement systems for assessing qualitative dimensions of
infant neurobehavior during the first year of life are lacking. This is unfortunate because empirical research suggests that prenatal drug exposure may
exert significant compromising effects on dimensions of infant attention
regulation and arousal modulation during this period. Struthers and HansenS1
reported that infants exposed to cocaine and amphetamines performed significantly worse than unexposed infants on the Fagan Test of Infant Intelligence,
a motor-free standardized test of visual attention and recognition. Alessandri
and colleagues3? found that infants who had been exposed to cocaine prenatally expressed less interest and joy during a learning task and less anger and
sadness during extinction than unexposed infants. Mayes and her cotleagues3S reported that three-month-old infants with a history of prenatal
cocaine and other drug exposure were more likely to cry and exhibit negative
affect during a novel stimulus presentation task and show greater decrements
in calming down to repeated presentations than same age unexposed infants.
In a related study, Mayes and colleagues34 found that infants in the exposed group were more likely to fail to start an habituation procedure and
were more irritable during the early part of the procedure than infants in the
unexposed group. Among the subset of infants who successfully completed
the habituation paradigm, however, no group differences in habituation performance were observed. Given the comparable performance between the
two groups on the habituation task, Mayes et
suggest the early effects of
drug exposure may be particularly evident in qualitative dimensions of infant
behavior such as arousal modulation and attention regulation, rather than
early cognitive abilities.
The aim of the present study was to evaluate the effect of prenatal cocaine
and other drug exposure on infants’ neurobehavioral functioning at 1, 4 and 7
months of age. Infants were observed longitudinally in multiple neuromotor
testing contexts at 1, 4 and 7 months of age. We hypothesized that infants who
had been exposed to cocaine would have poorer scores on measures of neurobchavioral functioning than unexposed infants at each assessment point.
METHOD

Subjects
Subjects included 49 infants: 23 control and 26 infants exposed to cocaine.
Detailed maternal and infant demographic information is provided in Table 1.
Of the 49 infants, 28 were females and 36 were African American. All were
full-term at birth, with birth weights appropriate for gestational age. All
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TABLE 1. Infant and Maternal Demographic Variables
CONTROL
(n = 23)

EXPOSED
(n = 26)

Gender
Male
Female

8
15

13
13

Race
Black
Hispanic
White

14
5
4

22
1
3

3276.91(443.6)

2960.37(420.4)

33.87 (5.60)
127.83 (7.92)
214.39 (4.46)

33.64 (6.00)
124.43 (7.03)
217.82 (5.11)

Age (years)*

22 9 (4.5)

28.3 (2.9)

Parity**

2.4 (1.1)

3.5 (2.0)

11.8

11.1

AFDC status-

100%

100%

ETOH*

2/20

19/21

MARIJUANA*

o/2o

8/21

TOBACCO*

5/20

17/21

Birthweight (g)**
Age at testing (days)
1 month
4 month
7 month**

Education (years)

* p < 0.01
** p < 0.05
)*AFDC Aid to Families with Deoendent Children

infants were from families living in urban, inner-city dwellings. Transportation to and from the study site was provided as w d l as a payment of $50 per
visit for their participation in the study. Of the 59 mothers who originally
agreed to participate in the study, 10 dropped out of the study: 1 from the
control group and 9 from the drug group. One infant died of sudden infant
death syndrome, 2 mothers were found to have used heroin during pregnancy
and 7 failed to keep their appointments.
Both infant-mother dyads of infants exposed to drugs and control infants
met the following criteria: (1) mother at least 18 years of age; (2) birth weight
equal to or greater than 2000 grams; ( 3 ) n o obvious major congenital malformations; (4) neonatal intensive care unit stay for no more than drug related
reasons, minor routine observation or septic work-up but with no evidence of
sepsis; ( 5 ) no requirements for mechanical ventilation; (6) no stigmata of
fetal alcohol syndrome o n neonatal examination; (7) no history of seroposi-
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tivity for HIV noted in the mother’s or infant‘s medical record; (8) mothers with
no seizure disorder and no medication for any psychiatric illness; (9) infant
discharged to mother’s or foster mother’s care from the nursery; and, (10) mother‘s willingness to give informed consent.
The mother-infant dyads of the drug exposed group were selected on the
basis of documented history from the medical chart of substance use during
pregnancy or on the basis of urine toxicology screens positive for cocaine
metabolites in the infant following delivery, in the mother at delivery, or
within one week before delivery as documented in the mother’s or infant’s
medical record.
On the basis of medical record review, control dyads delivering within two
months were matched to experimental dyads for mother’s education and
socioeconomic status as defined by method of paymcnt for medical care.
Control dyads also had no documentation in the mother’s prenatal record of
possible illicit substance use, no positive urine toxic screens for illicit substances at any time in the prenatal period, and no positive urine toxic screens
noted in the infant’s record. In addition, after receiving informed consent
from the infant’s mother, meconium samples were collected on all control
infants and screened for the presence of cocaine, opiates, phencyclidine,
amphetamine and marijuana by radioimmunoassay.

Procedure
This study was part of a larger study designed to examine neuromotor
development in infants exposed to cocaine at 1, 4 and 7 months of
Items measuring neurobehavioral functioning were scored from videotapes
of the neuromotor testing sessions. All subjects were tested under the same
laboratory conditions and submitted to identical procedures during testing.
At 1 month of age, all infants were tested on kinematic analysis and the
Alberta Infant Motor Scales (AIMS). At 4 and 7 months of age, all infants
were tested on kinematic analysis, the AIMS and the Movement Assessment
of Infants (MAI). All neuromotor testing sessions were videotaped. Of importance to this study was the “context” of testing rather than the actual
motor test as the types of events and handling procedures occurring during
testing became the stressful agent against which neurobehavioral functioning
would be measured in the infants.
Kinematic analysis captures and analyzes movement in three dimensions
through video tracking of the displacement of light reflecting markers placed
on the infant. During kinematic testing at 1 and 4 months, the infants were
placed in an infant seat and light reflecting markers were placcd on their
foreheads, wrists and ankles. The infants’ movements were observed under
three conditions lasting 2 minutes each: infant alone, with a rattle shaken in
front of the infant, and with the examiner interacting with the infant. During
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kinematic testing at 7 months, a reaching task was conducted. The infants
were seated in a high chair and light reflecting markers were placed on their
foreheads and wrists. The infants then reached up to 30 times for small
objects presented by the examiner.
The AIMS is a motor screening assessment made of 58 motor items
observed in four different positions: prone, supine, sitting and standing.36
After kinematic testing, the infant was undressed, placed on a floor mattress
and observed in each position. In order to pass an item, key motor descriptors
must be observed: aspects of weight bearing, posture and antigravity movement. The AIMS involves minimal handling and is designed to score the
observed motor behaviors elicited by the examiner, parent or age appropriate
toys.
The MA1 measures neurological and motor integrity through testing of 65
items divided into four sections on muscle tone, primitive reflexes, automatic
reactions and volitional movement.37 To score the MAI, a high-risk point is
given when an item differs from the scores listed on the high-risk profile. The
MA1 involves extensive infant handling to produce the required reactions.
Ideally, an infant had to be in an alert state for testing. If the infant became
fussy or cried, the examiner used different strategies in order to assist the
infant in maintaining or reaching a state suitable for testing. These strategies
could be mild (use of face, voice, touch, change of position, offer a toy,
time-out), moderate (pacifier, arm and leg containment, hand to mouth facilitation, shortened duration of tested item, time-out) or maximal (pick up and
hold, bottle, rock, walk, break with mother). If the baby still could not reach
and maintain an alert state for testing, the session was considered incomplete
and rescheduled. Even when rescheduled, some infants were still unable to
complete the requirements for kinematic, AIMS or MA1 testing; the kinematic session was either shortened or some items from the AIMS or MA1 were
left unscored. In these situations, the subject’s testing session was coded as
not completed.

Data Collection
The infants’ kinematic and neuromotor testing sessions were conducted by
examiners unaware of the exposure status of the infants. Measures of neurobehavioral functioning were coded from the videotaped neuromotor testing
sessions by one of the examiners (Y.B.). At each age, neurobehavioral scores
were determined based on the type of neuromotor testing (kinematics and
AIMS at 1 month; kinematics, AIMS and MA1 at 4 and 7 months). Infant and
maternal demographic information was available from three sources: the
infant’s and mother’s medical chart at recruitment, the Hobel, and a questionnaire completed by the mothers at the end of the study.
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Measures
The neurobehavioral items are listed in Table 2. For those items using a
scale from 1 to 9, a coding system was adapted from the NBAS supplementary items.38 The scale from l to 9 reflected the testing situation used in the
study and the typical responses seen in 1, 4 and 7 month old infants. An
example of the scoring scale for general irritability is shown in Table 3.
In the first phase of the study, a pilot sample of ten subjects (the first ten
subjects to be tested on kinematic, AIMS and MA1 at I, 4 and 7 months) was
scored on each of the rteurobehavioral items and the final definition of each
score determined. Following this first phase, intra and inter-rater reliability
was determined using intraclass correlation coefficient^.^^ To determine intra-rater reliability, the experimenter (Y.B.) coded the neurobehavioral items
from the testing sessions of the 10 pilot subjects and then recoded the items a
second time. To determine inter-rater reliability, one of the project’s research
assistants was trained on the coding system and codcd the neurobchavioral
itcms from 4 subjects previously coded by the experimenter. Intra-class coefficients (ICC) were calculated and were as follows (intra-rater; inter-rater):
number of state changes (0.97; 0.95); number of interruptions (1.0; 0.98);
number of breaks (1.0; 1.0); predominant state (0.95; 1.0); general irritability
(0.98; 1 .(I); quality of alert responsiveness (0.99; 0.94); regulatory capacity
(0.99; 0.97); tolerance to testing (0.98; 0.95); and, examiner persistence
(0.99; 0.96). All the ICC scores were indicative of high inter or intra-rater
reliabilit~.~~

Data Analyses
The groups were first compared on all maternal and infant demographic
variables using ANOVA or Chi-square analyses. For those continuous demographic variables on which significant group differences were found, correlations between that variable (confounder) and all outcome variables were
determined. In order to examine the influence of a confounder on outcome,
the study hypotheses were tested using hierarchical regression analyses for
all those outcome variables significantly correlated with a confounder. All
other outcome variables were compared using ANOVA or Chi-square tests.
RESULTS

Group Comparisons on Infant and Maternal Demographic Variables (Table 1)

The exposed infants were significantly lower in birth weight than the
control infants (p = 0.03) but birth weight was not significantly correlated
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TABLE 2. Definitions of Measures of Neurobehavioral Functioning
#of state changeslminute: the total number of state changes divided by the total number of minutes needed to complete testing.
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# breakslminute: the total number of breaks divided by the total number of minutes needed during testing. A break was a rest
period that occurredwhen the infant could not reach and maintain an alert state for testing.
4

# interruptions/min~e:the total number of interruptionsdivided by the total number of minutes needed for testing. An interruption
occurred when the infant had to be handled for adjustment or repositioning.
#visits: number of visits needed to complete testing.
Time duration: the length of time in minutes and seconds required for testing
Session completed: to indicate if testing was completed (yes) or partiallylnot completed (no). Results are presented as the
percentage of infants who completedthe testing session.
Predominant state: the most common state of consciousness observed during testing: deep sleep, light sleep. drowsy, alert, fussy,
crying. Results are presented as the percentage of infants with the alert state as the predominant state
during testing.
*Quality of alert responsiveness: quality of the alert infant's capacity to invest himself in a response to an animate or inanimate
stimuli (scale 1.9).
*Regulatory capacity: ability of the infant to maintain an alert state by himself during testing and the strategies demonstrated to
maintain and/or return to an alert state before requiringexaminer assistance (scale 1-9).

-

*General irritability: infant's response to handling and stimulus situations encountered during testing. It measures the number
of times the infant was irritable, the level of irritability and the kind of stimuli causing the irritability
(scale 1-9).
*Tolerance to testing: amount of stress induced by the demands of attention required during testing on the physiologic,motor
and state systems (scale 1-9).
*Examiner persistence: summary score of the amount of examiner assistance necessary to facilitate the infant's optimal
performance during testing (scale 1-9).

*scored only during AIMS and MA1testing

with any of the outcome variables. The age at testing at 7 months was
statistically higher for the exposed group when compared with the control
group (p = 0.02) and was significantly correlated with ratings of examiner
persistence at 7 months (r = -0.444. p = 0.04 Bonferroni corrected). The
exposed mothers were significantly older (p < .01), had more children (p =
0.04), and were more likely to use alcohol (p < .01), marijuana (p < .01) and
tobacco (p < .01) during pregnancy than control mothers (Table I). Of these
variables only maternal parity was significantly correlated with the number
of interruptions per minute during kinematic testing at 1 month (r = 0.458, p =
0.002) and 7 months (r = 0.366, p = 0.02).

Group Comparisons on Measures of Neurobehavioral Fiiizctioning
In the first phase of this analysis, group comparisons using ANOVA or
Chi-square tests were conducted for all outcome variables that were not
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TABLE 3. General Irritability Scoring Scale
The generalirritabilityscore reflectedthe infant’s responseto handlingand stimulussituations encounteredduring the examination.
Measures the number of times the infant was irritable, the level of irritability and the kind of stimuli which made himlher irritable.
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1-Irritable throughout the testing session. State 6 (crying) during most of the session. Irritability at beginningof examination that
increasedwith time. Examiner unsuccessful at calming infant, testing session terminatedearly.
2-Irritability began early during the testing procedure. Reached state 6 (crying) or 5 (fussing); needed break early in testing.
Remained irritable, calmed for brief periods but not long enough for testing to be continued. Testing procedure not completed.
3-Irritability beganduringor after AIMS was completed. Remainedeasilyirritable, reachingstate6 (crying) 1 or 2 times but mostly in
state 5 (fussing) during testing. Might not complete exam.
4-Easily irritable. However, state 6 (crying)reachedonly for very brief periods or baby heardcrying briefly duringtesting. Increased
fussiness and irritability over time. Needed break, recovered, but examiner might decide not to complete exam.
5-Some irritability with 2-3 episodes of state 5 (fussing). Fussiness was heard but able to complete session with examiner
interventionand time-out periods.
6-Reached state 5 (fussing) 1 or 2 times briefly. Returned to quiet alert state spontaneously or with mild examiner intervention.
Exam completed.
7-2 or more brief episodes of fussiness during testing but self-control regained rapidly, i.e., within 5 seconds. Might briefly reach
state 5 (fussing)once. Exam completed.

8-1-2 brief episodes of fussiness, did not reach state 5 (fussing) but fussing heard.
9-No irritability; infant respondedto all stimulus and handlingconditions with well-maintainedself-control.

correlated with a confounder. None of these analyses resulted in significant
group differences (Tables 4 and 5).
The second phase of analysis was conducted for those outcome variables
reported above that were significantly correlated with infant or maternal
demographic variables (confounders). Hierarchical regressions, as an approach to
analyses of covariance, 40 were used for this purpose. This approach allows
interpretation of the data in terms of variance accounted for by the covariate
and then any additional variance accounted for by group membership, in this
case drug exposurc (incremcnt in R’). For each analysis, the confounder was
entered first and then group membership. The increment in R’ was then
tested for significance and partial R2s computed for the group variable. Prior
to these analyses all interactions between the confounder and group membership were tested to rule out violation of the homogeneity of regression assumption. The inclusion of the interaction term in the regression analysis
tests for slope differences between drug exposed and control groups.
As can be seen in Table 6 the infants’ age at testing significantly predicted
examiner persistence at 7 months accounting for 9.7 percent of the variance
(R’ = .097). Drug exposure did not account for any additional variance
indicated by a zero increment in R2. A significant interaction between maternal parity and group for number of interruptions during kinematics testing at
1 month was found thus violating the homogeneity of variance assumption
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TABLE 4. Means, Standard Deviations and Percentages of Scores During
Kinematic Testing at I , 4 and 7 Months
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Dependent Variables

#visits
% session completed
# breaksiminute
# interruptionsiminute
Time duration
% predominant state 4
#state changesiminute

1 Month

4 Months

7 Months

Exposed

Control

Exposed

Control

Exposed

Control

1.17(,38)
63%
0.05(.07)
0.46(.31)
8.35(1.8)
75%
0.19(.18)

1.13(,34)
78%
0.05(.09)
0.27( .22)
8.16(2.1)
83%
0.15(.20)

1.19(.40)

1.17(.39)
74%
0.02(.05)
0.27(.19)
7.54(1.5)
91%
0.10(.17)

1.22(.42)
77%
0.02(.04)
0.83(.67)
10.81(2.1)
100%
0.07(.16)

1.14(.35)
77%
0.01(.03)
0.89(.75)
10.16(3.6)
91%
0.07(.17)

81%
0.01(.03)
0.24(.21)
7.43(1.1)
86%
0.08(.19)

TABLE 5. Means, Standard Deviations and Percentages of Scores During
AIMS Testing at 1 Month and AIMS/MAI Testing at 4 and 7 months
Dependent Variables

1 Month

Exposed
% session completed
# breaksiminute
# interruptionsiminute

Time duration
% predominant state 4
# state changesirninute
General irritability
Toleranceto testing
Examiner persistence
Quality alert responsiveness
Regulatory capacity

96%
O,OO(.OO)
0.07(.17)
3,20(1.2)
88%
0.1 8(.30)

4 Months

Control
95%
0.03(.13)
0.03(,09)
3.73(1 .I)
73%
0.25(.31)

7 Months

Exposed

Control

Exposed

Control

95%
0.03(.06)
0.01(.03)
17.14(3.4)
100%
0.08(.16)
7.33(1.6)
7.29(1.4)
6.86(1.9)
7.24(1.5)
7.57(1.6)

83%
0.04(.07)
0.02(.05)
18.03(2.3)
96%
0.10(.17)
6.65(2.4)
6.61(2.3)
6.39(2.4)
6.87(2.1)
6.87(2.3)

86%
0.03( .07)
0.02(.05)
16.02(2.9)
100%
0.09(.15)
6.96(2,1)
6.91(2.2)
7.09(2.1)
7.05(1.8)
7.18(2.2)

67%
0.03(.06)
0.002(.01)
17,49(3.2)
86%
0.07(.13)
6.71(2.4)
6.52(2,4)
6.48(2.6)
7.05( 1.9)
6.95(2.5)

indicating a significant slope difference and therefore making a regression
analysis invalid. Within group regressions of parity on this outcome variable,
however, indicated that parity predicted interruptions for the control infants
but was unrelated within the group of infants exposed to drugs. An outlier
within the group of infants exposed to cocaine (one mother with 10 children)
was then removed and the analysis rerun. Analysis of the interaction between
parity and group on interruptions at one month was still significant after
removal of this outlier. Within group regressions indicated that parity was
now significantly related to number of interruptions at one month for both
groups (see Table 6). Figure 1, however, illustrates that the slope of the
regression within the group of infants exposed to cocaine is much greater
indicating that increases in the need to interrupt testing occurred for infants
with fewer siblings in this group than for the control infants. The interaction
between parity and group was not significant for interruptions at 7 months
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TABLE 6. Hierarchical Regression Analyses of Covariance Results
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and hierarchical regression analyses indicated that drug exposure did nut
account for a significant amount of variance over and above that accounted
for by parity on this variable.

DISCUSSION
This study was designed to examine the possibility of persisting difficulties in neurobehavioral functioning beyond the neonatal period for infants
prenatally exposed to cocaine and other drugs. The available research, though
limited, suggests that the neurodevelopmental sequelae of prenatal drug exposure appear to be expressed primarily in the general domain of arousal
regulation experienced in novel or stimulating ~ituations."~'~Impaired
arousal regulation, in turn, influences infants' attentional capacities and their
reactivity to stimulation, including their responsivity to both inanimate and
animate stimuli.38 In this indirect way, prenatal drug exposure may exert
long-term compromising effects on children's learning. The lack of sensitive
instruments able to capture, at times subtle, neurobehavioral markers has
potentially contributed to the limited amount of research in this area beyond
the newborn period. This study represents a first attempt to examine neurobeliavioral functioning beyond the newborn period in infants exposed prenatally to cocaine and other drugs.
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FIGURE 1. Relation Between Maternal Parity and fnterrup~ion~/Minute
During Kinematic Testing at One Month
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The results of this longitudinal study, however, did not offer significant
support to prior empirical or clinical reports of increased irritability and
disrupted neurobehavioral functioning among older infants exposed to drugs.
None of the measures of neurobehavioral functioning showed any significant
group differences. Interestingly, some maternal and infant demographic variables showed more effects on neurobehavioral functioning than group exposure status. Age at testing at 7 months significantly predicted examiner persistence at 7 months but drug exposure did not (Table 6). The results shown
in Table 6 show a positivc correlation between examiner persistence and age
at testing at 7 months (0.311) indicating that older infants had higher scores
on examiner persistence, ie, they required less examiner persistence. Older
infants were thus easier to test. This relationship was as would be expected
even though measures of examiner persistence have not been normed for
infants beyond the newborn period.
A significant interaction was found between parity and group for the
number of interruptions during kinematic testing at 1 month of age. After
removal of an outlier in the drug exposed group (one mother had 1 0 children), parity was shown to be significantly related to number of interruptions
during kinematic testing at 1 month for both control (r = 0.543) and exposed
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groups (r = 0.523). As can be seen on the slopes shown in Figure 1, however,
this relationship was different between exposure groups. Fewer children were
required in the cocaine group to change the slope of the relationship between
the two variables. At one month of age, in the exposed group, an increase in
one child in the family caused the number of interruptions to increase whereas in the control group, an increase in two children in the family was needed
to cause an increase in the number of interruptions during kinematic testing.
The number of interruptions per minute was an indicator of the number of
additional or unplanned handling procedures introduced during testing. For
example, interruptions occured to reposition infants or when Velcro bands
holding the reflecting markers moved or detached; if an infant was very
active, the bands would move and the markers could no longer be seen by the
two recording cameras. Additionally, during kinematic testing at one month,
interruptions occured when the infant's posture had to be corrected. Some
infants showed an influence of the asymmetrical tonic neck reflex on their
posture; testing had to be interrupted to place the infant's head in midline in
order to minimize the influence of this reflex. Our results suggest that infants
with more siblings were more demanding in attention during kinematic testing at one month and that among the infants exposed to cocaine and other
drugs, the effects of parity occur with fewer siblings in the family. The reason
why parity influenced the number of interruptions at one month during kinematic testing is difficult to interpret. Possibly mothers who use drugs differ in
their handling of their infants when multiple childrcn are in the home and
perhaps are less able to divide their attention and respond to their infant's
needs for consoling. Mothers who use drugs may also be more stressed by an
additional child which could lead to difficulties in the development of organ ized behavior.
In this study, we could not determine if the infants' neurobehavioral scores
were within or below established norms. No such norms exist and very little
is known about neurobehavioral functioning beyond the newborn period. As
in most studies of prenatal drug exposure, the families from both groups in
this study were from low socioeconomic backgrounds and were benefiting
from AFDC assistance, more commonly known as welfare services. This bias
in the studied populations was also found in a study examining the prevalence of substance use during pregnancy.41 The results of that study showed
that, even though no racial or social class differences among the identified
substance using pregnant women were noted, black and poor women wcre
more likely to be reported for substance abuse while pregnant than their
white and middle class counterparts. Frank and colleagues4' have proposed
that long-term negative effects of prenatal cocaine exposure might be more
representative of outcome in a population of poor children living in d
and chaotic home environments. In a long-term follow-up study of children
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prenatally exposed to drugs, Chasnoff and colleagues suggested that low-income children, regardless of their prenatal drug exposure status, are at risk
for developmental delays early in life. In their study, children from both
groups scored below national norms on the Bayley Scales of Infant Development.16 The infants of this study also showed scores on the neuromotor
assessments, is., AIMS and MAI, that were below average for both groups.3s
To examine the effects of prenatal drug exposure without the co-morbid
influences of poverty, future studies would need to include groups of exposed
and control subjects from higher socioeconomic levels. In fact, socioeconomic status and mother’s level of education have long been recognized as significant predictors of developmental outcome in infants born
For this study, detailed information on the family home environment was
not collected. Although understudied, postnatal environmental factors such
as consistent, sensitive caregiving or early intervention services can significantly moderate the toxic effects of prenatal cocaine exposure and help pro>~~
mote healthy adaptation in children exposed to drugs p r e n a t a I l ~ .In~ ~one
longitudinal study, increased maternal sensitivity and maternal psychological
adaptation during the first year of life predicted higher Bayley scores in
infants prenatally exposed to cocaine and other drugs.47 In other research,48
mothers using drugs who received support services were more likely than
other mothers to provide a developmentally supportive environment for their
infants and to have infants whose developmental skills were age-appropriate
at age one. Similarly, Frank and colleagues49 showed that, among infants
heavily exposed to cocaine in utero, BSID scores during the first two years of
life were significantly higher if the infants or their caregivers had received
early intervention services. Although these factors were not measured in the
present study, their influence may have masked actual effects of prenatal drug
exposure on infant neurobehavioral functioning. In future studies with drug
exposed samples, the moderating effects of these environmental variables
should be assessed.
While neurobehavioral dysfunction has been reported for newborn inpants
exposed to cocaine and other drugs, these findings have not been consistently
replicated and have not been found to indicate severe neurobehavioral dysfunction. As these signs of dysfunction have not been readily demonstrated
beyond the newborn period, they might reflect only transient effects of prenatal exposure that are not present later in development. The possibility exists
that the outcome variables in this study were not sensitive enough to capture
subtle difficulties in neurobehavioral functioning in 1-, 4- and 7-month-old
infants. This is unlikely as the measures used in this study were adapted from
the NBAS neurobehavioral qualifiers, which are designed to assess these
dimensions. Besides the Qualifier Scoring System for Toddlers (QSS-T),23
no other comparable ncurobehavioral assessments for older infants are avail-
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able. The QSS-T, an adaptation of the NBAS supplementary items designed
for use with two-year-old children during structured testing contexts, was
able to discriminate between biologically high risk infants and lower risk
infants. The results of this study suggest that qualitative dimensions of functioning are sensitive measures of risk. More efforts in the design of such
instruments need to be made in the future.
Similar to the NBAS which uses the neurological examination as the
vehicle to induce stress in the newborn infant, the testing conditions imposed
in this study during kinematic assessment, AIMS, and MA1 testing placed
challenging demands on the infants. In fact, the general measures of neurobehavioral functioning at 4 and 7 months during AIMS and MA1 testing
showed a range of scores from 2 to 9. Although most of the infants showed
scores between 7 and 9, the presence of low scores indicated that the testing
conditions were able to elicit a wide range of behaviors, from organized to
disorganized, in the tested infants.
Some of the early research on prenatal cocaine exposure presented methodological weaknesses such as lack of control for polydrug use including
opiates, small sample size, inclusion of preterm infants, and lack of blind
examiner^.^' In this study, we attempted to control for confounding variables
and biases although still using a relatively small sample of polydrug users.
The subjects were all fullterm infants with birth weight above 2500 grams
and from the same (low) socioeconomic class, all control infants were free of
drug exposure, and the examiner was unaware of the exposure status of the
infants. All infants were tested in the same rooms at the three ages under an
identical protocol of testing. Despite these precautions, group differences
were not detected. Our findings do not support the presence of a marked or
persisting dysfunction in neurobehavioral organization among infants exposed to cocaine and other drugs. In future studies, infants and children from
all sub-groups of drug users, including middle class mothers, should be
examined in order to separate the effects of prenatal cocaine exposure from
the potential effects of suboptimal rearing environments.
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